The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer
NCT04018183 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 167
Last updated 2020-03-25
Summary
To understand the mechanism and cellular functions of PTK7-associated signaling pathways in promoting lung cancer progression and conferring treatment to epidermal growth factor receptor tysosine kinase inhibitors (EGFR TKIs).
Conditions
- Tumor Progression
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-19
- Primary Completion
- 2020-03-24
- Completion
- 2020-03-24
Countries
- Taiwan
Study Locations
More Related Trials
-
PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT
NCT05008796 ·Status: UNKNOWN
-
Genotyping of Non-small Cell Lung Cancer
NCT02002117 ·Status: UNKNOWN
-
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
NCT02422628 ·Status: UNKNOWN
-
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
NCT07316062 ·Status: RECRUITING
-
DNA Repair Genes and Outcomes in Patients With Stage III NSCLC
NCT00797238 ·Status: UNKNOWN
-
Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue
NCT01058811 ·Status: UNKNOWN
-
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
NCT04266691 ·Status: COMPLETED
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
The Research Plan of Taiwan Precision Medicine
NCT04849481 ·Status: RECRUITING
-
Therapeutic Resistance Prediction of Tyrosine Kinase Inhibitors
NCT02851329 ·Status: UNKNOWN
-
The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase
NCT02755337 ·Status: UNKNOWN
-
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NCT05701787 ·Status: RECRUITING
-
Methylation Status of CD44 Promoter Region in Primary Lung Cancer
NCT00173680 ·Status: UNKNOWN
-
SHOX2_PTGER4 DNA Methlyation in Lung Cancer
NCT04321499 ·Status: COMPLETED
-
Analysis of Plasma Tumor DNA in Lung Cancer Patients
NCT01930474 ·Status: UNKNOWN
-
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients
NCT05673798 ·Status: COMPLETED
-
Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLC
NCT01740804 ·Status: COMPLETED
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients
NCT01257308 ·Status: UNKNOWN
-
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
NCT06167460 ·Status: RECRUITING
-
Formatting the Risk Prediction Models for Never-Smoking Lung Cancer
NCT05572944 ·Status: RECRUITING
-
The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism
NCT01280448 ·Status: UNKNOWN
-
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121 ·Status: UNKNOWN
-
Non-small Cell Lung Cancer and Quality of Life
NCT00818402 ·Status: COMPLETED
-
A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under Chemotherapy
NCT03130192 ·Status: UNKNOWN